75 related articles for article (PubMed ID: 21232283)
1. gp130 signaling pathways: Recent advances and implications for cardiovascular disease.
Hirota H; Yoshida K; Taga T; Kishimoto T
Trends Cardiovasc Med; 1996 May; 6(4):109-15. PubMed ID: 21232283
[TBL] [Abstract][Full Text] [Related]
2. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
[TBL] [Abstract][Full Text] [Related]
5. gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities.
Nakashima K; Taga T
Semin Hematol; 1998 Jul; 35(3):210-21. PubMed ID: 9685167
[TBL] [Abstract][Full Text] [Related]
6. Differential stimulation-induced receptor localization in lipid rafts for interleukin-6 family cytokines signaling through the gp130/leukemia inhibitory factor receptor complex.
Port MD; Gibson RM; Nathanson NM
J Neurochem; 2007 May; 101(3):782-93. PubMed ID: 17448148
[TBL] [Abstract][Full Text] [Related]
7. [The interleukin-6 signal transducer, gp130, functioning in immune, hematopoietic, and neural systems].
Taga T
Nihon Rinsho; 1992 Aug; 50(8):1802-10. PubMed ID: 1433971
[TBL] [Abstract][Full Text] [Related]
8. The cytokine receptor gp130: faithfully promiscuous.
Müller-Newen G
Sci STKE; 2003 Sep; 2003(201):PE40. PubMed ID: 14506288
[TBL] [Abstract][Full Text] [Related]
9. [Advances in interleukin-6 therapy].
Ogata A; Nishimoto N; Yoshizaki K
Rinsho Byori; 1999 Apr; 47(4):321-6. PubMed ID: 10340005
[TBL] [Abstract][Full Text] [Related]
10. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
[TBL] [Abstract][Full Text] [Related]
12. CNTF/LIF/gp130 receptor complex signaling maintains a VZ precursor differentiation gradient in the developing ventral forebrain.
Gregg C; Weiss S
Development; 2005 Feb; 132(3):565-78. PubMed ID: 15634701
[TBL] [Abstract][Full Text] [Related]
13. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
14. The tripartite CNTF receptor complex: activation and signaling involves components shared with other cytokines.
Stahl N; Yancopoulos GD
J Neurobiol; 1994 Nov; 25(11):1454-66. PubMed ID: 7852997
[TBL] [Abstract][Full Text] [Related]
15. [Role of cytokine signaling in cardiomyopathy].
Takihara K
Nihon Rinsho; 2000 Jan; 58(1):228-32. PubMed ID: 10885319
[TBL] [Abstract][Full Text] [Related]
16. Vascular effects of glycoprotein130 ligands--part II: biomarkers and therapeutic targets.
Demyanets S; Huber K; Wojta J
Vascul Pharmacol; 2012 Aug; 57(1):29-40. PubMed ID: 22245786
[TBL] [Abstract][Full Text] [Related]
17. In vitro binding of ciliary neurotrophic factor to its receptors: evidence for the formation of an IL-6-type hexameric complex.
De Serio A; Graziani R; Laufer R; Ciliberto G; Paonessa G
J Mol Biol; 1995 Dec; 254(5):795-800. PubMed ID: 7500350
[TBL] [Abstract][Full Text] [Related]
18. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development.
Wollert KC; Chien KR
J Mol Med (Berl); 1997 Jul; 75(7):492-501. PubMed ID: 9253712
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 11: an overview.
Yang YC
Stem Cells; 1993 Nov; 11(6):474-86. PubMed ID: 8111307
[TBL] [Abstract][Full Text] [Related]
20. A ciliary neurotrophic factor-sensitive human myeloma cell line.
Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
